27
Jul
2015
Bad Behaviors Creeping Into Biotech During the Boom
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account. 
Share:
24
Jul
2015
The Amgen Seattle Alumni: Where Are They Now?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
21
Jul
2015
The Non-Compete Chill Has Passed: Bristol-Myers, MedImmune Settle Over I-O Star
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
21
Jul
2015
How Are Biotech VCs Performing in the Boom? You’d Be Surprised (Part 2)
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
20
Jul
2015
How Are Biotech VCs Performing in the Boom? You’d Be Surprised
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
17
Jul
2015
Forget Price Controls – Value-Based Pricing is the New Threat to Drug Development
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
9
Jul
2015
Happy (Belated) Independence Day! Timmerman Report is Here to Stay
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
7
Jul
2015
Pay Cut? That’s OK: Wall Street Veterans Find New Purpose in Biotech
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Jul
2015
Q&A With Shire CEO Flemming Ornskov on Becoming More ‘Biotech-Like’
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
29
Jun
2015
LinkedIn Is Integral to Biotech, But Some Still Don’t Get It
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
25
Jun
2015
The Cubist Alumni: Where Are They Now?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
22
Jun
2015
The Long Slog For Better Drug Safety Monitoring Is Paying Off
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
19
Jun
2015
Like the TR? Tell a Friend to Subscribe, and Enter to Win a T-Shirt
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
19
Jun
2015
Who’s Exploring DNA ‘Dark Matter’ for Drug Discovery?
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
15
Jun
2015
It’s Time to Re-Think Some Assumptions About Cancer R&D
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
11
Jun
2015
NEA, Polaris Bet $22M on Startup, Xtuit, to Break Down Tumor Microenvironment
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
8
Jun
2015
Bristol-Myers Should Drop the Bully Act. Non-Competes Are Bad for Biotech
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
5
Jun
2015
Cancer is Hot, Diabetes is Not: Watch for Drug Safety and Cost Debates at ADA
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
1
Jun
2015
Big Pharma Talent Is Flocking to Biotech Startups. Nobody’s Saying ‘Are You Nuts?’
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share:
29
May
2015
Cancer Immunotherapy’s Amazing Four-Year Run: A Timeline of Events
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
Share: